BONAVITA, EDUARDO
 Distribuzione geografica
Continente #
NA - Nord America 600
EU - Europa 154
AS - Asia 85
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 860
Nazione #
US - Stati Uniti d'America 598
IT - Italia 48
SG - Singapore 38
FI - Finlandia 36
CN - Cina 31
IE - Irlanda 21
NG - Nigeria 19
FR - Francia 11
GB - Regno Unito 10
BE - Belgio 7
IN - India 7
SE - Svezia 7
DE - Germania 5
TR - Turchia 5
NL - Olanda 4
CH - Svizzera 2
IL - Israele 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BR - Brasile 1
CA - Canada 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IR - Iran 1
JP - Giappone 1
PA - Panama 1
Totale 860
Città #
Wilmington 115
Chandler 97
Ann Arbor 52
San Mateo 44
Helsinki 36
Boardman 35
Singapore 29
Shanghai 28
Dublin 21
Leawood 20
Benin City 19
Lawrence 18
Princeton 18
Ashburn 17
Milan 13
Abbiategrasso 12
Paris 11
Woodbridge 11
Fairfield 10
Brussels 7
Redmond 7
San Diego 6
Falls Church 5
Kocaeli 5
London 5
Amsterdam 4
New York 4
Seattle 4
Norwalk 3
Pune 3
Rome 3
Andover 2
Beijing 2
Los Angeles 2
Triggiano 2
Augusta 1
Brno 1
Chavannes-sur-Moudon 1
Elk Grove Village 1
Guangzhou 1
Hanover 1
Houston 1
Leighton Buzzard 1
Manchester 1
Mumbai 1
Redwood City 1
São Paulo 1
Toronto 1
Vienna 1
Totale 684
Nome #
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors 71
Occurrence and significance of tumor - Associated neutrophils in patients with colorectal cancer 66
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade 60
Negative regulatory receptors of the IL-1 family 59
Interplay between Myeloid Cells and Humoral Innate Immunity 55
The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling. 54
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity 54
The Humoral Pattern Recognition Molecule PTX3 Is a Key Component of Innate Immunity against Urinary Tract Infection 51
Tumor associated macrophages and neutrophils in cancer 44
The Long Pentraxin PTX3 as a Key Component of Humoral Innate Immunity and a Candidate Diagnostic for Inflammatory Diseases 42
Decoys and regulatory "receptors" of the IL-1/Toll-like receptor superfamily 41
TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor family member with regulatory functions in inflammation and immunity 40
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer 40
Neutrophils driving unconventional T cells are essential for resistance to sarcomas 35
Role of Toll Interleukin-1 Receptor (IL-1R) 8, a Negative Regulator of IL-1R/Toll-Like Receptor Signaling, in Resistance to Acute Pseudomonas aeruginosa Lung Infection 34
PTX3 acts as an extrinsic oncosuppressor 33
Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity 30
Phagocytes as Corrupted Policemen in Cancer-Related Inflammation 28
Neutrophil diversity in inflammation and cancer 12
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies 8
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control 6
Neutrophils mediate protection against colitis and carcinogenesis by controlling bacterial invasion and IL-22 production by γδ T cells 6
Plasmacytoid dendritic cells alter the antitumor activity of CpG-oligodeoxynucleotides in a mouse model of lung carcinoma 4
Anti-inflammatory drugs remodel the tumor immune environment to enhance immune checkpoint blockade efficacy 4
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 4
The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network 3
The activation of liver X receptors inhibits toll-like receptor- 9-induced foam cell formation 3
Resolving the dark side of therapy-driven cancer cell death 3
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 3
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations 3
Totale 896
Categoria #
all - tutte 6.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/2021256 8 1 6 4 1 76 34 19 45 38 0 24
2021/2022137 6 0 1 26 2 3 7 13 23 16 22 18
2022/2023290 41 12 26 28 31 20 3 23 58 28 18 2
2023/2024203 15 12 35 8 4 10 10 16 11 16 18 48
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 896